BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16038022)

  • 1. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data.
    Haab BB; Geierstanger BH; Michailidis G; Vitzthum F; Forrester S; Okon R; Saviranta P; Brinker A; Sorette M; Perlee L; Suresh S; Drwal G; Adkins JN; Omenn GS
    Proteomics; 2005 Aug; 5(13):3278-91. PubMed ID: 16038022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
    Omenn GS; States DJ; Adamski M; Blackwell TW; Menon R; Hermjakob H; Apweiler R; Haab BB; Simpson RJ; Eddes JS; Kapp EA; Moritz RL; Chan DW; Rai AJ; Admon A; Aebersold R; Eng J; Hancock WS; Hefta SA; Meyer H; Paik YK; Yoo JS; Ping P; Pounds J; Adkins J; Qian X; Wang R; Wasinger V; Wu CY; Zhao X; Zeng R; Archakov A; Tsugita A; Beer I; Pandey A; Pisano M; Andrews P; Tammen H; Speicher DW; Hanash SM
    Proteomics; 2005 Aug; 5(13):3226-45. PubMed ID: 16104056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
    Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
    Rai AJ; Gelfand CA; Haywood BC; Warunek DJ; Yi J; Schuchard MD; Mehigh RJ; Cockrill SL; Scott GB; Tammen H; Schulz-Knappe P; Speicher DW; Vitzthum F; Haab BB; Siest G; Chan DW
    Proteomics; 2005 Aug; 5(13):3262-77. PubMed ID: 16052621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional liquid chromatography/tandem mass spectrometry analysis of Gradiflow fractionated native human plasma.
    Wasinger VC; Locke VL; Raftery MJ; Larance M; Rothemund D; Liew A; Bate I; Guilhaus M
    Proteomics; 2005 Aug; 5(13):3397-401. PubMed ID: 16104060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of electrophoretically derived protein mass estimates as additional constraints in proteome analysis of human serum based on MS/MS analysis.
    Kim JY; Lee JH; Park GW; Cho K; Kwon KH; Park YM; Cho SY; Paik YK; Yoo JS
    Proteomics; 2005 Aug; 5(13):3376-85. PubMed ID: 16052618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human plasma proteome: analysis of Chinese serum using shotgun strategy.
    He P; He HZ; Dai J; Wang Y; Sheng QH; Zhou LP; Zhang ZS; Sun YL; Liu F; Wang K; Zhang JS; Wang HX; Song ZM; Zhang HR; Zeng R; Zhao X
    Proteomics; 2005 Aug; 5(13):3442-53. PubMed ID: 16047309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project.
    Adamski M; Blackwell T; Menon R; Martens L; Hermjakob H; Taylor C; Omenn GS; States DJ
    Proteomics; 2005 Aug; 5(13):3246-61. PubMed ID: 16104057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes.
    Tang HY; Ali-Khan N; Echan LA; Levenkova N; Rux JJ; Speicher DW
    Proteomics; 2005 Aug; 5(13):3329-42. PubMed ID: 16052622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Plasma PeptideAtlas.
    Deutsch EW; Eng JK; Zhang H; King NL; Nesvizhskii AI; Lin B; Lee H; Yi EC; Ossola R; Aebersold R
    Proteomics; 2005 Aug; 5(13):3497-500. PubMed ID: 16052627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centralized data analysis of a large interlaboratory proteomics project: a feasibility study.
    Beer I; Barnea E; Admon A
    Proteomics; 2005 Aug; 5(13):3491-6. PubMed ID: 16052626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system.
    Misek DE; Kuick R; Wang H; Galchev V; Deng B; Zhao R; Tra J; Pisano MR; Amunugama R; Allen D; Walker AK; Strahler JR; Andrews P; Omenn GS; Hanash SM
    Proteomics; 2005 Aug; 5(13):3343-52. PubMed ID: 16047307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects.
    Hosnijeh FS; Krop EJ; Portengen L; Rabkin CS; Linseisen J; Vineis P; Vermeulen R
    Biomarkers; 2010 Mar; 15(2):140-8. PubMed ID: 19848603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS.
    Yang Z; Hancock WS; Chew TR; Bonilla L
    Proteomics; 2005 Aug; 5(13):3353-66. PubMed ID: 16052617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
    Cho SY; Lee EY; Lee JS; Kim HY; Park JM; Kwon MS; Park YK; Lee HJ; Kang MJ; Kim JY; Yoo JS; Park SJ; Cho JW; Kim HS; Paik YK
    Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses.
    Omenn GS
    Proteomics; 2004 May; 4(5):1235-40. PubMed ID: 15188391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis.
    Kapp EA; Schütz F; Connolly LM; Chakel JA; Meza JE; Miller CA; Fenyo D; Eng JK; Adkins JN; Omenn GS; Simpson RJ
    Proteomics; 2005 Aug; 5(13):3475-90. PubMed ID: 16047398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics.
    Rai AJ; Vitzthum F
    Expert Rev Proteomics; 2006 Aug; 3(4):409-26. PubMed ID: 16901200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.